Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T20:13:07.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the previous v3.4.1. No study data or key page content appear to be affected.
    Difference
    0.0%
    Check dated 2026-02-13T12:26:05.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 and no user-facing content or study details were changed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T23:45:07.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Show glossary and Hide glossary options were added to control glossary visibility. Capitalization adjustments were made for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a new 'Revision: v3.4.0' stamp was introduced.
    Difference
    0.2%
    Check dated 2026-01-22T17:42:17.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no substantive changes to the Study Details page were observed in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:52:02.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Updated the study locations section to include detailed site locations by state/province and country (including Minsk Oblast, Ontario, and Quebec) and updated the revision to v3.3.3.
    Difference
    2%
    Check dated 2025-12-17T20:20:59.000Z thumbnail image

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.